Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-based medical products

Fig. 2

Amplification curve of HBV diluted standard. The value of ΔRn indicates the amount of probe degradation during PCR, which is the amount of PCR product. Valid detection limit of HBV PCR fluorescence quantitative detection kit was 100 IU/ml

Back to article page